DIAN-TU at Washington University in St. Louis
Research Services • 
St Louis, Missouri, United States • 1-10 Employees
Company overview
| Headquarters | 4488 Forest Park Ave, St Louis, Missouri 63108, US |
| Website | |
| NAICS | 5417 |
| Employees | 1-10 |
| Socials |
Key Contact at DIAN-TU at Washington University in St. Louis
Silvy Alexander
Assistant Director, Clinical Operations
About DIAN-TU at Washington University in St. Louis
The DIAN-TU has launched the world’s first prevention trial for at-risk families with DIAD. This interventional therapeutic trial focuses on drugs that could potentially change the course of the disease. It evaluates the safety, tolerability and effectiveness of these drugs and will determine if they can prevent, delay, or possibly even reverse Alzheimer’s disease changes in the brain. The clinical trial is designed and coordinated by the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), based at Washington University School of Medicine in St. Louis.
DIAN-TU at Washington University in St. Louis revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
DIAN-TU at Washington University in St. Louis has never raised funding before.
Austria
New Zealand
United Kingdom
Frequently asked questions
4.8
40,000 users
